Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Marc Matrana"'
Autor:
Richa Goel, Zoe Blake, Karine Tawagi, Diana Maslov, Victoria Simenson, Helen Yuan, Cameron Parent, Adi Bamnolker, KC Madhav, Marc Matrana
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/acfdf965b300485ea5f6e0b596a013aa
Autor:
John H Strickler, Antonio Cubillo, Jin-Tung Liang, Marc Matrana, Mark Kozloff, Thomas Lowe, Martha Blaney, Mohammad Sahtout, Louie Naumovski, Zev A Wainberg
Publikováno v:
Future Oncology. 18:3011-3020
Aim: This phase II study investigated safety and efficacy of dilpacimab or bevacizumab plus FOLFIRI in patients with previously treated metastatic colorectal cancer (mCRC). Materials & methods: Overall, 66 patients were treated (n = 34 dilpacimab + F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1c01fa7f5da30351406a1f56ba4f79
https://doi.org/10.2217/fon-2021-1603
https://doi.org/10.2217/fon-2021-1603
Autor:
Iben Spanggaard, Marc Matrana, Caio Rocha-Lima, Amit Mahipal, Maria Vieito, Alice Hervieu, Myung-Ju Ahn, Lipika Goyal, Jordi Rodon Ahnert, Luisa Veronese, Natalia Oliveira, Xin Li, Michael Schaffer, Santosh Kesari
Publikováno v:
Monday, April 24.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba29a2372f6f1eaab09dc490d73b74b8
https://doi.org/10.1212/wnl.0000000000203833
https://doi.org/10.1212/wnl.0000000000203833
Autor:
Razelle Kurzrock, Charles D. Blanke, Melissa Plets, Christopher W. Ryan, Edward Mayerson, Elad Sharon, Helen X. Chen, Christine McLeod, Jourdain Hayward, W. Michael Korn, Zoran Gatalica, Marc Matrana, Tareq Al Baghdadi, Anup Kasi, Manisha H. Shah, Annette Fontaine, Preet Paul Singh, Donna E. Hansel, Francis J. Giles, Young Kwang Chae, Megan Othus, Sandip P. Patel
Purpose:Immune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the results of the (nonpancreatic) neuroendocrine neoplasm cohort of SWOG S1609 dual anti–CTLA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e764ebbb5f97894227c92dd11d1eff
https://doi.org/10.1158/1078-0432.c.6528908
https://doi.org/10.1158/1078-0432.c.6528908
Autor:
Nizar M. Tannir, Keith Orford, Lalith Akella, Hema Parmar, Zhentao Zhang, Yousef Zakharia, Arash Rezazadeh Kalebasty, Petros G. Nikolinakos, Oscar B. Goodman, Benjamin A. Gartrell, Alice C. Fan, Johanna Bendell, Montaser Shaheen, Vijay Patel, Steven McCune, Sandy Liu, Ulka Vaishampayan, Arif Hussain, James J. Hsieh, Ivor Percent, Marc Matrana, Hamid Emamekhoo, Robert Motzer, Chung-Han Lee
Purpose:Glutaminase is a key enzyme, which supports elevated dependency of tumors on glutamine-dependent biosynthesis of metabolic intermediates. Dual targeting of glucose and glutamine metabolism by the mTOR inhibitor everolimus plus the oral glutam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a186504f410b1b44c1a1931aa5a0590
https://doi.org/10.1158/1078-0432.c.6532388
https://doi.org/10.1158/1078-0432.c.6532388
Autor:
Nizar M. Tannir, Keith Orford, Lalith Akella, Hema Parmar, Zhentao Zhang, Yousef Zakharia, Arash Rezazadeh Kalebasty, Petros G. Nikolinakos, Oscar B. Goodman, Benjamin A. Gartrell, Alice C. Fan, Johanna Bendell, Montaser Shaheen, Vijay Patel, Steven McCune, Sandy Liu, Ulka Vaishampayan, Arif Hussain, James J. Hsieh, Ivor Percent, Marc Matrana, Hamid Emamekhoo, Robert Motzer, Chung-Han Lee
Supplementary Figure from Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2715c83537f8cbfd72bcae33f511a58f
https://doi.org/10.1158/1078-0432.22486787
https://doi.org/10.1158/1078-0432.22486787
Autor:
Nizar M. Tannir, Keith Orford, Lalith Akella, Hema Parmar, Zhentao Zhang, Yousef Zakharia, Arash Rezazadeh Kalebasty, Petros G. Nikolinakos, Oscar B. Goodman, Benjamin A. Gartrell, Alice C. Fan, Johanna Bendell, Montaser Shaheen, Vijay Patel, Steven McCune, Sandy Liu, Ulka Vaishampayan, Arif Hussain, James J. Hsieh, Ivor Percent, Marc Matrana, Hamid Emamekhoo, Robert Motzer, Chung-Han Lee
Supplementary Table from Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327aa368f9769c6d320925d88254c103
https://doi.org/10.1158/1078-0432.22486784.v1
https://doi.org/10.1158/1078-0432.22486784.v1
Autor:
Razelle Kurzrock, Charles D. Blanke, Melissa Plets, Christopher W. Ryan, Edward Mayerson, Elad Sharon, Helen X. Chen, Christine McLeod, Jourdain Hayward, W. Michael Korn, Zoran Gatalica, Marc Matrana, Tareq Al Baghdadi, Anup Kasi, Manisha H. Shah, Annette Fontaine, Preet Paul Singh, Donna E. Hansel, Francis J. Giles, Young Kwang Chae, Megan Othus, Sandip P. Patel
Appendix
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c8e67fd9cfcbfbc976dd7fde7eda278
https://doi.org/10.1158/1078-0432.22474763
https://doi.org/10.1158/1078-0432.22474763
Autor:
Annette Fontaine, Anup Kasi, Jourdain Hayward, Tareq Al Baghdadi, Manisha Shah, Melissa Plets, Megan Othus, Razelle Kurzrock, Edward Mayerson, Zoran Gatalica, Francis J. Giles, Christopher W. Ryan, Donna E. Hansel, Christine M. McLeod, Sandip Pravin Patel, Elad Sharon, Helen X. Chen, Marc Matrana, W. Michael Korn, Preet Paul Singh, Young Kwang Chae, Charles D. Blanke
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 26, iss 10
Clin Cancer Res
Clin Cancer Res
Purpose: Immune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the results of the (nonpancreatic) neuroendocrine neoplasm cohort of SWOG S1609 dual anti–CTL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af0a5916b106134919751addb6c490a4
https://doi.org/10.1158/1078-0432.ccr-19-3356
https://doi.org/10.1158/1078-0432.ccr-19-3356
Autor:
Chung-Han Lee, Robert Motzer, Hamid Emamekhoo, Marc Matrana, Ivor Percent, James J. Hsieh, Arif Hussain, Ulka Vaishampayan, Sandy Liu, Steven McCune, Vijay Patel, Montaser Shaheen, Johanna Bendell, Alice C. Fan, Benjamin A. Gartrell, Oscar B. Goodman, Petros G. Nikolinakos, Arash Rezazadeh Kalebasty, Yousef Zakharia, Zhentao Zhang, Hema Parmar, Lalith Akella, Keith Orford, Nizar M. Tannir
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(15)
Purpose: Glutaminase is a key enzyme, which supports elevated dependency of tumors on glutamine-dependent biosynthesis of metabolic intermediates. Dual targeting of glucose and glutamine metabolism by the mTOR inhibitor everolimus plus the oral gluta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76bbc0ca1ab53acba9eb114883a5090d
https://pubmed.ncbi.nlm.nih.gov/35576438
https://pubmed.ncbi.nlm.nih.gov/35576438